Targeting toxins to treat whooping cough
Whooping cough is an infectious respiratory disease caused by the bacteria Bordetella pertussis. According to the U.S. Centers for Disease Control and Prevention, whooping cough cases are rising. While early antibiotic treatment can be effective, most diagnoses do not occur until after this therapeutic window has passed.

In a recent Journal of Biological Chemistry article , Stefanie Lietz from Ulm University, Germany, and an international team explored the human peptidome — the complete collection of peptides in the human body — for pertussis toxin, or PT, inhibitors using peptide libraries, fractionation and mass spectrometry. They identified the liver protein α1-antitrypsin, or α1AT, as a potent PT inhibitor. Additional cell culture and molecular modeling experiments indicated that α1AT likely binds to PT in solution and thus blocks the toxin from making contact with its known host glycoprotein cell surface interaction partner for endocytosis.
Patients with genetic α1AT deficiency receive synthetic α1AT in the clinic. Therefore, α1AT may be able to be repurposed to treat PT-mediated pertussis pathogenesis. Future studies will fill in details about α1AT’s mechanism of action against PT, such as verifying the α1AT residues involved in binding PT.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Spider-like proteins spin defenses to control immunity
Researchers from Utrecht University discovered two distinct binding modes of a spider-shaped immune inhibitor found in serum.

A biological camera: How AI is transforming retinal imaging
AI is helping clinicians see a more detailed view into the eye, allowing them to detect diabetic retinopathy earlier and expand access through tele-ophthalmology. These advances could help millions see a clearer future.

AI in the lab: The power of smarter questions
An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.